Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Select Medical Holdings (SEM) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Select Medical Holdings (SEM) over the last 17 years, with Q3 2025 value amounting to 5.35%.

  • Select Medical Holdings' EBITDA Margin rose 10300.0% to 5.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.46%, marking a year-over-year increase of 40100.0%. This contributed to the annual value of 7.89% for FY2024, which is 4200.0% down from last year.
  • According to the latest figures from Q3 2025, Select Medical Holdings' EBITDA Margin is 5.35%, which was up 10300.0% from 6.46% recorded in Q2 2025.
  • Over the past 5 years, Select Medical Holdings' EBITDA Margin peaked at 120.13% during Q4 2022, and registered a low of 14.23% during Q4 2023.
  • For the 5-year period, Select Medical Holdings' EBITDA Margin averaged around 13.12%, with its median value being 7.63% (2022).
  • Its EBITDA Margin has fluctuated over the past 5 years, first soared by 1151600bps in 2022, then tumbled by -1343600bps in 2023.
  • Over the past 5 years, Select Medical Holdings' EBITDA Margin (Quarter) stood at 4.97% in 2021, then surged by 2317bps to 120.13% in 2022, then plummeted by -112bps to 14.23% in 2023, then surged by 111bps to 1.61% in 2024, then surged by 233bps to 5.35% in 2025.
  • Its EBITDA Margin was 5.35% in Q3 2025, compared to 6.46% in Q2 2025 and 8.33% in Q1 2025.